{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T02:40:44Z","timestamp":1772160044789,"version":"3.50.1"},"reference-count":6,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T00:00:00Z","timestamp":1554076800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T00:00:00Z","timestamp":1554076800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100013598","name":"American Acne and Rosacea Society","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100013598","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaad.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Academy of Dermatology"],"published-print":{"date-parts":[[2019,4]]},"DOI":"10.1016\/j.jaad.2018.09.039","type":"journal-article","created":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T21:56:27Z","timestamp":1538430987000},"page":"1135-1137","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Trends in utilization of topical medications for treatment of rosacea in the United States (2005-2014): A cohort analysis"],"prefix":"10.1016","volume":"80","author":[{"given":"Hadar","family":"Lev-Tov","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joanne S.","family":"Rill","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guodong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joslyn S.","family":"Kirby","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"6 Suppl 1","key":"10.1016\/j.jaad.2018.09.039_bib1","doi-asserted-by":"crossref","first-page":"S27","DOI":"10.1016\/j.jaad.2013.04.043","article-title":"Rosacea: current state of epidemiology","volume":"69","author":"Tan","year":"2013","journal-title":"J Am Acad Dermatol"},{"issue":"6","key":"10.1016\/j.jaad.2018.09.039_bib2","first-page":"277","article-title":"Consensus recommendations from the American Acne & Rosacea Society on the management of rosacea, part 2: a status report on topical agents","volume":"92","author":"Del Rosso","year":"2013","journal-title":"Cutis"},{"key":"10.1016\/j.jaad.2018.09.039_bib3","first-page":"1","article-title":"Dose, duration, and cost: opportunities to improve use of long-term oral antibiotics for people with rosacea","author":"Rill","year":"2018","journal-title":"J Dermatolog Treat"},{"issue":"3","key":"10.1016\/j.jaad.2018.09.039_bib4","doi-asserted-by":"crossref","first-page":"145","DOI":"10.7326\/M16-1432","article-title":"High generic drug prices and market competition: a retrospective cohort study","volume":"167","author":"Dave","year":"2017","journal-title":"Ann Intern Med"},{"issue":"2","key":"10.1016\/j.jaad.2018.09.039_bib5","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1257\/pol.20150588","article-title":"When discounts raise costs: the effect of copay coupons on generic utilization","volume":"9","author":"Dafny","year":"2017","journal-title":"Am Econ J Econ Policy"},{"issue":"1","key":"10.1016\/j.jaad.2018.09.039_bib6","first-page":"41","article-title":"Healthcare utilization and costs of patients with rosacea in an insured population","volume":"7","author":"Romanowicz","year":"2008","journal-title":"J Drugs Dermatol"}],"container-title":["Journal of the American Academy of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962218326501?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962218326501?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T22:47:58Z","timestamp":1759272478000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0190962218326501"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4]]},"references-count":6,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019,4]]}},"alternative-id":["S0190962218326501"],"URL":"https:\/\/doi.org\/10.1016\/j.jaad.2018.09.039","relation":{},"ISSN":["0190-9622"],"issn-type":[{"value":"0190-9622","type":"print"}],"subject":[],"published":{"date-parts":[[2019,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Trends in utilization of topical medications for treatment of rosacea in the United States (2005-2014): A cohort analysis","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Academy of Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaad.2018.09.039","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 by the American Academy of Dermatology, Inc.","name":"copyright","label":"Copyright"}]}}